Role of C1q/TNF-Related Protein 6 for the Evaluation of Coronary Heart Disease Associated with Type 2 Diabetes
Mianxian Li,Shuru Zhou,Zexiong Feng,Chi Zhang
DOI: https://doi.org/10.2147/tcrm.s464007
2024-05-21
Therapeutics and Clinical Risk Management
Abstract:Mianxian Li, 1, &ast Shuru Zhou, 2, &ast Zexiong Feng, 1, &ast Chi Zhang 1 1 Department of Cardiology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, People's Republic of China; 2 The Aoyang Cancer Institute, Affiliated Aoyang Hospital of Jiangsu University, Suzhou, Jiangsu, People's Republic of China &astThese authors contributed equally to this work Correspondence: Chi Zhang, Email Objective: Coronary artery disease (CAD) and type 2 diabetes (T2DM) are closely associated with increased rate of death. C1q/TNF-related protein 6 (CTRP6) is a novel adipocytokine which plays an important role in glucose and lipid metabolism. Little is known about the function of CTRP6 in CAD and T2DM patients. Herein, we aimed to study the association of CTRP6 level with CAD and T2DM. Methods: This study included 51 CAD, 44 CAD+T2DM and 65 non-CAD+T2DM patients from Affiliated Aoyang Hospital of Jiangsu University. Serum CTRP6 concentrations were detected by ELISA. Multiple logistic regression was used to analyze the association of serum CTRP6 with CAD and T2DM. Results: Serum CTRP6 concentrations were significantly lower in CAD patients than controls. However, there is no significant statistical difference between CAD+T2DM patients and non-CAD+T2DM patients. Serum CTRP6 was negatively correlated with low-density lipoprotein cholesterol (LDL-C) ( ρ =− 0.2769, p=0.028) in controls. Serum CTRP6 was positively correlated with age ( ρ =0.4121, p=0.0027), systolic blood pressure (SBP) ( ρ =0.4012, p=0.0035), Creatinine ( ρ =0.3295, p=0.0194), uric acid (UA) ( ρ =0.3386, p=0.0162), and left ventricular end diastolic diameter (LVD) ( ρ =0.4277, p=0.0042) and negatively correlated with ejection fraction (EF) ( ρ =− 0.3237, p=0.0342) in CAD patients. Serum CTRP6 was negatively correlated with high-density lipoprotein cholesterol (HDL-C) ( ρ =− 0.3164, p=0.0387) in CAD+T2DM patients. Multiple logistic regression showed that the decrease of CTRP6 was significantly related to the increased prevalence of CAD. What is more, CTRP6 increased prevalence of T2DM in CAD patients. Conclusion: Lower serum CTRP6 could be a risk factor of CAD. However, higher circulating CTRP6 associated with the increased prevalence of T2DM in CAD patients. Keywords: CTRP6, coronary artery disease, type 2 diabetes, adipokine, CTRP, risk factor Cardiovascular mortality has fallen in developed countries during the past four decades. 1 However, mortality has persistently increased in China. Based on epidemiological survey, there are 330 million cardiovascular disease (CVD) patients in China. 2 CVD continues to be a leading cause of death around the world. 3 Diabetes mellitus (DM) is a metabolic disease characterized by hyperglycemia and impaired islet secretion. By 2025, the number of DM patients is expected to rise to 300 million around the world. 4 DM is now the seventh leading cause of death in the worldwide. 5 T2DM accounts for more than 90% of the total number of DM. It has far-reaching effect on the health and economy. 6 Previous study showed that T2DM had a higher mortality rate for CVD compared with controls. 7 Hence, we should pay more attention to patients with CVD and T2DM. C1q/TNF-related protein (CTRP) family is a newly identified and highly conserved family which contains 15 members (CTRP1-CTRP15). 8 Each CTRP has its own specific distribution in vivo and exerts diverse functions. 9 CTRP family has attracted a lot of attention because it plays an important role in energy homeostasis, inflammation and myocardial protection and vasodilation. 10 CTRP6 is a novel adiponectin including 259 amino acids. It contains four different domains, comprising signal peptide, short N-terminal variable region, collagen domain and C-terminal C1q domain. 11 CTRP6 expressed abundantly in adipose tissue, heart, brain, and so on. 12 Previous studies showed that CTRP6 participated the regulation of endothelial cell function angiotensin II–induced hypertension. 13 Wang et al reported that CTRP6 was related with insulin resistance. Circulating CTRP6 levels increased in T2DM patients in Chinese population. 14 According to previous researches concerning the relationship between CTRP6 and endothelial cell function, circulating CTRP6 might be a potential marker of CAD. The association between CTRP6 and T2DM has been evaluated. However, the role of CTRP6 in CAD has not been well described. Accordingly, in this study, we aimed to assess the association between CTRP6 level -Abstract Truncated-
health care sciences & services